Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Redeem Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it will redeem all of its outstanding 3.25 percent convertible senior subordinated notes due 2024.

The firm said that $329,229,000 million in aggregate principal amount of the notes was outstanding as of Feb. 25, 2011. The notes will be redeemed on March 30 at 100 percent of their principal amount plus accrued and unpaid interest to the redemption date, said Thermo Fisher.

Last week, the company sold $2.2 billion in senior notes, which will be used to pay for its acquisition of Dionex.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.